Combined vitreous and cataract surgeries in highly hyperopic eye
Makoto Inoue1,2, Kei Shinoda3, Tomoko Matsuda-Yamamitsu2, Ronaldo Yuiti Sano1, Susumu Ishida2,4
1Kyorin Eye Center, Kyorin University School of Medicine, Mitaka, Tokyo, Japan; 2Department of Ophthalmology, Keio University School of Medicine, Shinjuku, Tokyo, Japan; 3Department of Ophthalmology, Teikyo University School of Medicine, Itabashi, Tokyo, Japan; 4Department of Ophthalmology, Hokkaido University School of Medicine, Sapporo, Hokkaido, Japan
Abstract: We report a case of a patient with a highly hyperopic eye who underwent cataract surgery combined with vitreous surgery to create a posterior vitreous detachment (PVD) to prevent choroidal neovascularization (CNV). A 78-year-old man noticed a decrease in his vision due to a cataract in his right eye. The patient had a severe visual loss in his left eye because of a CNV 2 years after a cataract surgery. His visual acuities were 20/30 OD and 20/600 OS, and funduscopic examination showed an orange-colored lesion OD and degenerative subretinal fibrosis OS. The posterior vitreous was attached to the retina in both eyes. The axial length was 18.9 mm OD and 19.0 mm OS. Cataract surgery combined with vitreous surgery to create PVD was performed on the right eye, and the vision improved to 20/20 with no signs of developing CNV after 5 years. We conclude that cataract surgery combined with vitreous surgery to create a PVD may prevent the development of CNV in highly hyperopic eyes.
Keywords: hyperopia, macular degeneration, posterior vitreous detachment, cataract surgery
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.